PRE

Prenetics Global Limited Class A Ordinary Share (PRE)

Stock · NASDAQ · Finance

$18.56as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

Prenetics Global Releases Q2 2026 Earnings Call Transcript. Prenetics Global has published the full transcript of its Q2 2026 earnings call. The transcript provides details on the company’s financial performance, guidance, and strategic initiatives. Investors can review the discussion to better understand the company’s outlook. The release follows the company’s recent earnings announcement.

Active signals

Support level
$17.7
Industry
Blank Checks

What PRE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike32-4.1%47%
Bollinger Band BreakdownActive now27-0.5%44%
Bollinger Band Breakout22-7.5%36%
200-Day Moving Average TouchActive now5-5.7%40%
Any 20-session window (baseline)-4.0%40%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About PRE

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headq…

Sector
Finance
Industry
Blank Checks
Employees
98

Fundamentals

1-day range
$19.71$20.38
Market cap
$306.18M
P/E (trailing)
—
P/E (forward)
-7.64
EPS (trailing)
$-2.88
Dividend yield
—
Beta
0.33
Avg. volume
211.5K
52-week range
$11.37$27.24
Next earnings: November 10, 2026 · EPS estimate $-1.00confirmed

Forecasts

8 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$54
+191.0%
Median
$36.5
+96.7%
Low
$30
+61.7%

Prenetics Global Limited Class A Ordinary Share Competitors

Chosen by industry and closest market cap.

  • PRE
    Prenetics Global Limited Class A Ordinary Share
    $18.52
    ▼ 8.59%
    Market cap $306.18MP/E —
    $11.37$27.24
  • INV
    Innventure Inc. Common Stock
    $0.328
    ▲ 11.19%
    Market cap $292.48MP/E —
    $0.2388$7.86
  • OXSQ
    Oxford Square Capital Corp. Common Stock
    $1.31
    ▼ 6.43%
    Market cap $156.54MP/E —
    $1.05$2.05
  • MLEC
    Moolec Science SA Ordinary Shares
    $1.68
    ▼ 10.16%
    Market cap $4.95MP/E —
    $1.62$23.22
  • APXTW
    Apex Treasury Corporation Warrants
    $0.29
    ▼ 1.99%
    Market cap $—P/E —
    $0.2$0.7499
  • ATIIU
    Archimedes Tech SPAC Partners II Co. Unit
    $9.01
    ▲ 2.62%
    Market cap $—P/E 36.97
    $7.59$11.4
  • ASPCU
    A SPAC III Acquisition Corp. Unit
    $11.22
    ▲ 0.00%
    Market cap $—P/E 60.43
    $10.3$63.98

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
202.7K
Disposed
1.35M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.